JP TSE 4540 Pharmaceutical

Tsumura & Co.

株式会社ツムラ

Revenue

¥193B

≈ $1.2B

Net income

¥28.1B

≈ $178.2M

Income taxes paid

¥12.6B

≈ $80.0M

Total assets

¥593B

≈ $3.8B

Equity ratio

62.7%

Ranked #330 among listed Japanese companies by corporate taxes paid · effective tax rate 26.3%.

Share price at fiscal year-end: ¥3,748 · market capitalization ¥288B · P/E 10.0 · P/B 0.77

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥193B	¥28.1B	¥10.8B	¥12.6B	¥593B	¥372B	62.7%	EDINET (consol.)
Mar 2025	¥181B	¥32.4B	¥11.0B	¥5.9B	¥464B	¥330B	71.1%	EDINET (consol.)
Mar 2024	¥151B	¥16.7B	—	—	¥428B	¥295B	69.0%	EDINET (consol.)
Mar 2023	¥140B	¥16.5B	—	—	¥397B	¥272B	68.6%	EDINET (consol.)
Mar 2022	¥130B	¥18.8B	—	—	¥351B	¥258B	73.5%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.